Lung surgery without a breathing tube: a gentler path to recovery?
NCT ID NCT06574295
First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time
Summary
This trial tests whether removing lung nodules with non-intubated video-assisted thoracic surgery, which avoids a breathing tube and ventilator, helps patients recover faster and feel better than traditional intubated surgery. Researchers will compare symptom burden, quality of life, and hospital stay length in about 876 adults aged 18 to 75 who need minimally invasive lung surgery. They will also assess the procedure's cost-effectiveness and patient preferences to guide broader adoption.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Non-intubated video-assisted thoracic surgery (VATS), a surgical procedure that removes lung nodules without using a breathing tube or mechanical ventilation
- What this could lead to
- If successful, this approach could become a standard option for lung nodule removal, offering faster recovery and fewer anesthesia-related complications.
- What could go wrong
- The trial is observational, so it cannot prove cause and effect. Results may vary by patient and hospital, and the procedure may not suit everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
876 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Jan 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of adult patients aged 18 to 75 years who have been diagnosed with pulmonary nodules or lung cancer and are scheduled for minimally invasive thoracic surgery. These patients will be divided into two groups: an experimental group undergoing non-intubated video-assisted thoracic surgery (VATS) and a control group undergoing intubated VATS. Both groups include individuals who are able to tolerate surgery based on preoperative evaluations, regardless of gender. All participants must provide informed consent and agree to complete the required follow-up assessments.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Experimental Group (Non-intubated Video-assisted Thoracic Surgery): 1. Patients diagnosed with pulmonary nodules or lung cancer who are scheduled for minimally invasive surgery (including wedge resection, segmentectomy, or lobectomy). 2. Aged between 18 and 75 years, regardless of gender. 3. Preoperative assessment indicates that the patient can tolerate non-intubated video-assisted thoracic surgery. 4. The patient has signed an informed consent form and voluntarily agrees to participate in the study. Control Group (Intubated Video-assisted Thoracic Surgery): 1. Patients diagnosed with pulmonary nodules or lung cancer who are scheduled for minimally invasive surgery (including wedge resection, segmentectomy, or lobectomy). 2. Aged between 18 and 75 years, regardless of gender. 3. Preoperative assessment indicates that the patient can tolerate minimally invasive surgery. 4. The patient has signed an informed consent form and voluntarily agrees to participate in the study. Exclusion Criteria: 1. Patients unable to provide sufficient preoperative and postoperative follow-up data. 2. Pregnant or breastfeeding women. 3. Patients with severe cardiopulmonary dysfunction preoperatively, making them unfit for surgery. 4. Patients who have previously undergone surgery or radiotherapy in the same chest region. 5. Patients with active infections or other severe comorbidities that may affect surgical outcomes. 6. Patients with mental illness or cognitive impairment who cannot understand the study content or comply with follow-up requirements.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lung cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Hebei University
Baoding, Hebei, 071000, China
-
Affiliated Hospital of Jining Medical University
Jining, Shandong, 272029, China
-
Anhui Chest Hospital
Hefei, Anhui, 230022, China
-
Anning First People's Hospital
Anning, Yunnan, 650300, China
-
Anyang Tumor Hospital
Anyang, Henan, 455001, China
-
Binzhou Medical University Hospital
Binzhou, Shandong, 256603, China
-
Cangzhou Central Hospital
Cangzhou, Hebei, 061001, China
-
Chongqing General Hospital
Chongqing, Chongqing Municipality, 401147, China
-
Deyang People's Hospital
Deyang, Sichuan, 618000, China
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350001, China
-
Guangxi Zhuang Autonomous Region Nanxishan Hospital
Guilin, Guangxi, 541002, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
-
School of Public Health, Fudan University
Shanghai, Shanghai Municipality, 200032, China
-
Shaoxing People's Hospital
Shaoxing, Zhejiang, 312000, China
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China
-
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, 830054, China
-
The First People's Hospital of Yunnan Province
Kunming, Yunnan, 650032, China
-
The Second Affiliated Hospital of University of South China
Hengyang, Hunan, 421001, China
-
The Second Hospital of Shandong University
Jinan, Shandong, 250033, China
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
-
Wuhan Central Hospital
Wuhan, Hubei, 430014, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A spoonful of olive oil before lung surgery: a new shield against a rare complication?
- Mobile lung cancer clinics aim to close rural screening gap
- Can protein patterns in stored tumors point to new treatment targets?
- A single blood draw to detect five cancers before symptoms appear?
- A breath sniff could one day screen for lung cancer and more
- Can a radioactive antibody light up hidden tumors on PET scans?